drugset / Trial / NCT01091532
A Study In Healthy People Of Multiple Doses Of UK-396,082 Given By Mouth, To Investigate The Safety, Toleration And Time Course Of Blood Concentration Of UK-396,082 And Its Effects.
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study in healthy people is to investigate the safety, toleration and time course of UK-396,082 concentration in the blood and any changes in relevant markers of drug effects, following multiple doses given twice daily by mouth for 14 days.
Timeline
- Start
- 2010-03
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | UK-396,082 | Small molecule | 100 mg | Oral |
| Subject | UK-396,082 | Small molecule | 300 mg | Oral |
| Subject | UK-396,082 | Small molecule | 1000 mg | Oral |
Indications
No indication recorded.